Illumina NovaSeq 6000 sequencing; MCT1 causes resistance to SMAD3 inhibition in cancer and involves dysregulation of the cholesterol synthesis pathway (CRISPR-KO screen)
European Bioinformatics Institute
E-MTAB-15085:NT_1